https://www.avient.com/sites/default/files/2020-03/2020proxy.pdf
a) Section 5 Section 9
(b)
(c)
(d) Section 8
(e)
(i)
Person
Outstanding
Company Voting Securities
(ii)
Incumbent Board
(iii)
Business Combination
(iv)
(f)
(g)
Section 12
(h)
(i)
Section 13
(j)
Section 10
Section 10
(k)
(l)
(m)
(n)
(o)
Section 5 Section 9
(p)
(q)
(r)
(s)
(t)
(u)
Section 4 Section 9
(v)
(w)
Section 8
(x)
Section 8
(y) Section 8
(z)
(aa)
(bb) Section 6
Section 9
(cc) Section 7 Section 9
(dd)
Section 7 Section 9
(ee)
(ff)
(gg)
Section 5 Section 9
(hh)
3.
Shares Available Under this Plan
(a)
(i) Section 12
Section 3(b) ( )
Section 9 Section 10
2017 Plan
(ii) Section 3(b)( )
Section 3(a)(i) ( )( )
(b)
(i) Section 22
Section 3(a)(i) ( )( )
(ii)
(iii)
Section 3(a)(i) ( )( )
Section 3(a)(i) ( )( )
Section 3(a)(i)( )( )
Section 3(a)(i)( )( )
(iv)
Section 3(a)(i)( )( )
(c)
Section 3
Section 12
(d)
Section 3
(e)
Section 3(e)( )
Section 3(a)(i) Section 12( )( )
Section 3(e)( )
Section 17(c)( )
4.
a)
(b)
(c)
(d)
(e)
(f)
8.
https://www.avient.com/products/thermoplastic-elastomers/tpe-knowledge-center/technical-bulletins/specific-gravity
The part volume would be 1.5 in^3 (5x3x0.100) or 24.6 cm^3 (1.5 x 16.4).
XL9070: 24.6 cm^3 x 0.89 = 21.8 g
G7970: 24.6 cm^3 x 1.18 = 29.0 g
Injection Molding: Troubleshooting
https://www.avient.com/investor-center/news/polyone-declares-quarterly-dividend-increase-30-announces-three-year-dividend-increase-plan
Our cash flow generation, financial profile and earnings potential have never been stronger, and we are very well positioned to deliver double digit EPS growth in 2018 and beyond."
You are advised to consult any further disclosures we make on related subjects in our reports on Form 10-Q, 8-K and 10-K that we provide to the
https://www.avient.com/investor-center/news/future-mobility-innovations-gain-traction-visionary-polyone-materials-and-services-portfolio
plans to present additional details about transportation solutions as one of several high-growth focus areas that underpin the company's expectation of delivering double digit EPS growth in 2018 and beyond.
You are advised to consult any further disclosures we make on related subjects in our reports on Form 10-Q, 8-K and 10-K that we provide to the
https://www.avient.com/investor-center/news/advanced-composites-avient-lightweighting-solutions-fuel-efficiency
As a result, our composites portfolio continues to be a key area of growth that we expect to expand double digits annually in the years to come."
You are advised to consult any further disclosures we make on related subjects in our reports on Form 10-Q, 8-K and 10-K that we provide to the
https://www.avient.com/resources/safety-data-sheets?page=5871
XDW WB DIGITAL CLEAR
PP FR 8-6 LMS-1000
https://www.avient.com/sites/default/files/2023-11/AVNT Q3 2023 Earnings Presentation - Website.pdf
AVIENT CORPORATION
T H I R D Q U A R T E R 2 0 2 3 R E S U L T S
(NYSE: AVNT)
N O V E M B E R 2 , 2 0 2 3
D I S C L A I M E R
Forward-Looking Statements
Certain statements contained in or incorporated by reference into this presentation constitute “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995.
Prior Year
8
Q3 2023 PERFORMANCE VS.
GUIDANCE
$800
$754
Guidance Actual
$128
$123
Guidance Actual
Sales Adjusted EBITDA
(in millions)
$0.56 $0.57
Guidance Actual
Adjusted EPS
(in millions)
9
• Demand impacted by destocking
and cautious customer sentiment
• Positive net price benefit:
o CAI - Pricing flat and raw
material deflation
o SEM - Pricing flat with
unfavorable mix related to
healthcare, more than offset
with raw material deflation
• Cost reductions driven by Clariant
synergies and reduced
administrative costs
Q3 EBITDA BRIDGE
($ millions)
CAI:
Price / Mix -)
Deflation 22)
SEM:
Price / Mix (6)
Deflation 13)
Net Price Benefit 29)
Cost Reductions 13)
Wage Inflation (8)
FX 1)
Q3 2023 Actual $ 123)
Adjusted
EBITDA
Q3 2022 Pro Forma $ 137)
Demand (49)
10
2 0 2 3 G U I D A N C E
Q4 2023 GUIDANCE VS.
https://www.avient.com/investor-center/news/polyone-announces-fourth-quarter-and-full-year-2019-results
8:00 a.m.
Attachment 3
Tax adjustments (Attachment 3)
https://www.avient.com/sites/default/files/2023-02/turkisk-entity-legal-information-en-tu.pdf
İNTERNET SİTESİ İÇERİĞİ
POLYONE TEKNO POLİMER MÜHENDİSLİK PLASTİKLERİ SANAYİ VE TİCARET
ANONİM ŞİRKETİ
Şirket Bilgileri (Yönlendirilmiş Mesaj)
No İçerik Detay
1 Ticaret Unvanı Polyone Tekno Polimer
Mühendislik Plastikleri Sanayi
ve Ticaret Anonim Şirketi
2 MERSİS Numarası 0836003561100014
3 Merkezi Orhan Gazi Mah.1683 Sk.
No:8 Esenyurt/İstanbul
4 Taahhüt Edilen Sermaye Miktarı 100.799.000,00 TL
5 Ödenen Sermaye Miktarı 100.799.000,00 TL
6 Yönetim Kurulu Üyeleri
• Holger Hans Kronimus
(Yönetim Kurulu Başkanı)
• Christoph Palm (Yönetim
Kurulu Başkan Yardımcısı)
• Zaneta Gabriela Potoczny
(Yönetim Kurulu Üyesi)
7 Bağımsız Denetçi Ticaret Unvanı: Elit Bağımsız
Denetim ve Yeminli Mali
Müşavirlik Anonim Şirketi
Adresi: Halaskargazi Cad.
No Content Detail
1 MERSIS number of the Company 0836003561100014
2 Title of the Company Polyone Tekno Polimer
Mühendislik Plastikleri Sanayi
ve Ticaret Anonim Şirketi
3 Registered office of the Company Orhan Gazi Mah.1683 Sk.
https://www.avient.com/sites/default/files/2020-11/investing-in-avient_0.pdf
You are advised to consult any further disclosures we make on related subjects in our reports on Form 10-Q, 8-K and 10-K that we provide to the Securities and Exchange Commission.
These investments also
consider our global footprint, and we are positioned very well and
strategically from a regional perspective.
9
Growth Drivers
2020E
Revenue
($ Millions)
Long-Term
Growth Rate
Sustainable Solutions $ 550 8–12%
Healthcare 560 8–10%
Composites / 5G 210 10%
Growth in Emerging Regions 650 5%
Other (GDP growth) 1,730 2–3%
Pro Forma Avient $ 3,700 6.5%
(1) Avient Sustainable Solutions definitions aligned with FTC 2012 Guide for the Use of Environmental Marketing Claims (“Gree n Guides”)
(2) 2020 is estimated and Pro forma to include full year of the Clariant Masterbatch business
S U S TA I NA B L E S O LU T I O N S
Avient has a highly technical and broad portfolio of material solutions
that help our customers—and our planet—be more sustainable.
Whether
an additional line at an existing
manufacturing plant, or a new
facility in a growing region, we
ramp-up quickly and cost-efficiently.
17
Capex / Revenue
2021E (%)
Source: Bloomberg market data as of November 9, 2020
AV I E N T I S A S S E T L I G H T
Avient Specialty
Formulators
Other
Chemical/Specialty
Companies
2
3 2 2 3 3
3
6
3 4
5 5 5 5
5 6 6
7
7
9
24
A
v
ie
n
t
A
v
ie
n
t
(E
x
c
l.